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NMR Structural Characterization of Substrates Bound to NAcetylglucosaminyltransferase V
Megan A. Macnaughtan, Maria Kamar, Gerardo Alvarez-Manilla, Andre Venot, John
Glushka, J. Michael Pierce, and James H. Prestegard*
Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia

Summary
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N-acetylglucosaminyltransferase V (GnT-V) is an enzyme involved in the biosynthesis of
asparagine-linked oligosaccharides. It is responsible for the transfer of N-acetylglucosamine
(GlcNAc) from the nucleotide sugar donor, UDP-GlcNAc, to the 6 position of the α-1–6 linked Man
residue in N-linked oligosaccharide core structures. GnT-V up-regulation has been linked to
increased cancer invasiveness and metastasis and, appropriately, targeted for drug development.
However, drug design is impeded by the lack of structural information on the protein and the way in
which substrates are bound. Even though the catalytic domain of this type II membrane protein can
be expressed in mammalian cell culture, obtaining structural information has proved challenging due
to the size of the catalytic domain (95 kDa) and its required glycosylation. In this manuscript, we
present an experimental approach to obtaining information on structural characteristics of the active
site of GnT-V through the investigation of the bound conformation and relative placement of its
ligands, UDP-GlcNAc and β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)-β-D-GlcpOOctyl. Nuclear
magnetic resonance (NMR) spectroscopy experiments, inducing transferred nuclear Overhauser
effect (trNOE) and saturation transfer difference (STD) experiments, were used to characterize the
ligand conformation and ligand-protein contact surfaces. In addition, a novel paramagnetic relaxation
enhancement experiment using a spin-labeled ligand analogue, UDP-TEMPO, was used to
characterize the relative orientation of the two bound ligands. The structural information obtained
for the substrates in the active site of GnT-V can be useful in the design of inhibitors for GnT-V.
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Introduction
Proteins are often characterized as to function, connected to disease, and validated as potential
drug targets prior to complete physical characterization. This is the case for the Nacetylglucosaminyltransferase V (GnT-V, also called GnT-VA),1,2,3,4 which is clearly linked
to the progression of carcinomas by a number of studies, including those with GnT-V null mice
that show inhibition of breast carcinoma progression and metastasis.5 GnT-V has been
sequenced, expressed, and kinetically evaluated using various substrates, but no structural
information exists. While drugs can be developed in the absence of structural information, this
lack of knowledge certainly impedes progress. Ideally, three dimensional structures of proteins
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are obtained through investigations of the protein itself using X-ray crystallography or NMR
spectroscopy, but these approaches often prove challenging. In this manuscript we explore the
possibility of obtaining structural information about the active site of GnT-V indirectly through
investigation of the conformation and relative placement of its natural ligands and analogues
of those ligands. The approach is based on widely used NMR techniques for the
characterization of ligand conformation (transfer nuclear Overhauser effect, trNOE,
spectroscopy) and ligand-protein contact surfaces (saturation transfer difference, STD,
spectroscopy). It also incorporates a novel approach to the relative placement of ligands using
spin-labeled analogues of one ligand to restrict placement of a second ligand.
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GnT-V and its family members represent challenging targets for structural characterization for
a number of reasons. GnT-V is classified as a family 18 glycosyltransferase in the CAZy
database (Carbohydrate Active Enzymes database, http://www.cazy.org/).6,7 Currently, this
family has no structural representatives in the Protein Data Bank.8 GnT-V and other members
of family 18 are type II membrane proteins. Membrane proteins are challenging for structural
characterization; fortunately, the catalytic domain of GnT-V without the membrane domain
has been successfully expressed and purified.9 The catalytic domain has three, occupied Nglycosylation consensus sites, at least some of which are necessary for maintaining activity.
10 To attain proper glycosylation it is necessary to express the protein in mammalian cells.
The resulting heterogeneous glycosylation and the limited yields in mammalian cell expression
are an obstacle to the production of crystals suitable for X-ray crystallography. Heterogeneity
of glycosylation is less of an obstacle to NMR structure determination. However, even a
minimal construct for the catalytic domain of 66 kDa (produced by proteolysis) is large for
structure determination by NMR. Also, the need to express GnT-V in mammalian cells makes
uniform 13C, 15N isotope labeling used in NMR structure determination prohibitively
expensive, and 2H labeling used for work on large proteins nearly impossible.
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With respect to substrate interaction as a potential probe of active site structure, GnT-V offers
a number of opportunities. GnT-V catalyzes the transfer of an N-acetylglucosamine (GlcNAc)
from the nucleotide sugar donor, UDP-GlcNAc, to the 6 position of the α-1–6 linked Man
residue in an oligosaccharide containing the native β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)[β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)]-D-Manp motif, or a close synthetic analogue. The
addition occurs with inversion of configuration at the anomeric site, consistent with a
mechanism in which both substrates occupy the active site simultaneously. In our case we will
use a synthetic acceptor analogue discovered by Srivastava, et al., β-D-GlcpNAc-(1→2)-α-DManp-(1→6)-β-D-GlcpOOctyl, in place of native acceptors that are more difficult to obtain.
11 The synthetic acceptor contains the required β-D-GlcpNAc-(1→2)-α-D-Manp but has a
(1→6) linked Glc rather than Man due to increased ease of synthesis. The Glc is linked to an
octyl chain that allows for separation of product in the GnT-V activity assay by reverse-phase
solid-phase extraction,12 but is also required for enzyme transfer, since acceptors lacking the
octyl group show very little or no transfer of substrate. The donor substrates used were the
native UDP-GlcNAc and an analogue that has a TEMPO derivative in place of the GlcNAc
moiety. The presence of both, rather large, donor and acceptor substrates presents the
opportunity of probing a substantial portion of the protein’s active site pocket.
The dominant methods for determining bound conformations and binding motifs of substrates
include trNOE spectroscopy and STD spectroscopy. Use of trNOEs has been extensively
reviewed and there are a number of applications to carbohydrates bound to proteins.13 trNOEs
are acquired using standard 2D NOE sequences to monitor correlations among ligand
resonances and provide distance constraints between proximate pairs of protons. Use in cases
where ligands are rapidly exchanging between bound and free forms is particularly
advantageous because excess ligand (10–30 X) can be used to improve sensitivity while NOEs
from the bound state still dominate the observed average. This weighted average occurs because
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of the linear dependence of magnetization transfer rates on correlation times for large systems.
STD spectroscopy is of more recent vintage and is used to identify binding epitopes on the
surfaces of ligands. Spectra are collected with and without saturation of regions of the spectrum
containing only protein resonances. In the presence of excess ligand, differences between the
spectra primarily show resonances belonging to ligand protons in close proximity to protein
protons. STD depends on the efficient spin diffusion of magnetization among protons within
large proteins and the transfer of this magnetization from protein to ligand protons in a 1/r6
dependent fashion.

NIH-PA Author Manuscript

The third method used for investigation of ligand geometry is intended to retrieve information
on the relative placement of the two ligands in the binding pocket. In principle, this could be
determined using inter-ligand NOEs from the trNOE experiments, but these data are limited
by the requirement of very close approach and reduction of signal due to partial occupations
of each site. An alternate approach uses perturbation of spin relaxation by the presence of an
unpaired electron on one of the ligands. Relaxation of spins on the other ligand is enhanced
with the same 1/r6 distance dependence as an NOE, but because the magnetic moment of an
electron is on the order of 1000 times that of a proton, the distance range is larger. The unpaired
electron in our case was introduced by replacing the GlcNAc in UDP-GlcNAc with a nitroxide
containing TEMPO moiety. This compound is a novel addition to a set of tools that might be
used to investigate properties of a number of glycosyltransferases. Use of TEMPO analogues
to retrieve structural constraints is well established in systems where the nitroxides are
covalently attached to a protein and amide protons of the protein are observed; here distances
between protons and nitroxide as large as 20 Å have been characterized.14 In our case we
detect relaxation effects by introducing spin relaxation delays in the preparation period
of 1H-13C HSQC experiment of rapidly exchanging ligands. The 2D HSQC experiment
provides the resolution needed to individually monitor effects on a large number of sites on
the acceptor in the presence of the TEMPO analogue of the sugar donor.
Modeling of all data collected provides a picture of bound ligand geometry that constrains the
active site of a structurally uncharacterized protein. In principle, the geometry could be used
to begin to rationally design inhibitors that could modulate activity of an enzyme whose activity
can regulate the invasiveness and metastatic potential of malignant cells.

Results
Binding Epitopes from Saturation Transfer Difference

NIH-PA Author Manuscript

Saturation transfer difference spectroscopy was used to determine the binding epitopes of the
acceptor, the donor (UDP-GlcNAc), and the non-paramagnetic form of the donor analogue
(UDP-TEMPOH). The results of these experiments are illustrated in Figures 1, 2, and 3. Each
figure includes a reference spectrum of the compound, the STD spectrum of the compound in
the presence of GnT-V, and the normalized STD percentages. The indicated assignments of
resonances were completed using COSY and TOCSY as well as reference to literature
assignments.15,16 The background signal from GnT-V was subtracted from each STD
spectrum to improve the baseline and analysis of the spectra. The highest STD percentages for
UDP-GlcNAc and UDP-TEMPOH are localized on the uridine portion of the molecules with
values greater than 60% for H6, H5, H1’, H2’, and H3’. A saturation frequency of 7.1 ppm
was used instead of 0.0 ppm for the UDP-TEMPOH experiment to avoid saturating impurities
in the UDP-TEMPOH sample that have resonances near 0.0 ppm. To rule out the possibility
that this change alters response, a STD experiment with UDP-GlcNAc was performed with
7.1 ppm irradiation. The STD values were very similar to the values obtained at 0.0 ppm (data
not shown).
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The results for the acceptor indicate that the highest STD percentages are localized on the
GlcNAc ring and octyl chain with contacts greater than 50% at H3”, H4”, H5”, H6S”, H6R”,
and at the protons on the terminal 6 carbons of the octyl chain [–(CH2)5CH3]. An additional
STD experiment was performed with the acceptor in which UDP was added. A high
concentration (10 mM UDP) was used to maximize the occupancy since the Kd is 3.8 mM.
17 Otherwise, identical conditions were used as in the acceptor STD experiment. The results
of this experiment are compared to the acceptor results in Figure 4. The STD contacts of the
acceptor to GnT-V do not change significantly when UDP is present.
Bound Conformations from Transferred NOE
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Intramolecular 1H-1H distances for the donor and acceptor substrate separately bound to GnTV were determined using 1D trNOE and 2D trNOESY experiments. 2D NOESY spectra taken
of UDP-GlcNAc with and without GnT-V are included as supplementary data. NOEs in the
presence of GnT-V are negative, as expected in a case where contributions from the bound
form dominate. A minimum of structural data is available in this case with only a single
conformationally variant NOE constraint observed for pairs of protons on different rings of
UDP-GlcNAc. This constraint is between uracil H6 and ribose H2’. Qualitatively this supports
an anti conformation for the nucleoside glycosidic bond. Intensities can be more quantitatively
interpreted in terms of distances using 1D NOE spectra in which NOE mixing times are varied.
Such spectra were collected for both free and bound UDP-GlcNAc and data are shown in Figure
5. Assuming a rigid model and using the H5-H6 distance and NOE data as a reference, the
distances between H6 and H2’ for free UDP-GlcNAc and UDP-GlcNAc in the presence of
GnT-V were both determined to be 2.5 +/− 0.1 Å.
trNOESY spectra of UDP-TEMPOH with GnT-V were collected to verify binding and identify
distance constraints. Like UDP-GlcNAc, negative NOEs were observed for UDP-TEMPOH
in the presence of GnT-V, indicating that UDP-TEMPOH binds GnT-V. The only distance
constraint observed was again between H6 and H2’. The distance was calculated from
trNOESY spectra similarly to the UDP-GlcNAc calculation and was determined to be 2.5 +/
− 0.1 Å. As with UDP-GlcNAc, no NOEs were observed between the TEMPOH ring and the
uridine portion of the UDP-TEMPOH molecule.
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NOESY spectra were collected on the acceptor with and without GnT-V. Figure 6 shows an
expansion of the glycosyl region; the full spectra are available as supplementary materials. Due
to the overlap of several resonances of the acceptor and interference from protein resonances,
the spectra were collected at 900 MHz. Based on their positions and relatively narrow lines,
the interfering protein signals must arise from glycosyl residues on the protein which exhibit
significant flexibility relative to the protein. These background signals were identified by
observing the protein alone at a mixing time of 200 ms as shown in Figure 6c. The chemical
shifts of the background signals are typical of oligosaccharides containing GlcNAc, Man, Gal,
and NeuAc, which are constituents of GnT-V’s glycosylation.10 The GnT-V background
NOESY spectrum was carefully compared to the trNOESY acceptor spectrum. Crosspeaks
with significant overlap with protein signals were not used in the analysis of
intermolecular 1H-1H distances of the acceptor.
Unlike the donor spectra, the NOESY spectrum of the acceptor free in solution (Figure 6a)
gives some negative (sugar residues) NOEs in addition to positive (octyl chain) NOEs. The
intensities are also small, being 1–2 % at a mixing time of 800 ms. It can be inferred that the
correlation time of the acceptor free in solution is approximately 1.2 ns, which is a little long
for a molecular weight of 658 g/mole. It has been suggested that the acceptor forms micelles
due to the hydrophobic octyl chain, and some tendency to formation of micelles could lengthen
the effective correlation time. Nevertheless, due to their small size, the negative NOEs of the
free acceptor do not contribute significantly to the NOEs of the GnT-V bound acceptor. The
J Mol Biol. Author manuscript; available in PMC 2008 March 2.
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negative NOEs for the H1’-H2’ pair in the presence of GnT-V (Figure 6b) become
approximately 40 times larger for intra-ring interactions showing the expected enhancement
from bound ligand contributions (the time evolution data for the H1’-H2’ pair is provided as
supplemental material). Even after discounting crosspeaks from the protein, Figure 6b shows
a number of crosspeaks not observed in the free acceptor. They offer the possibility of
extracting additional distance constraints that can be used in modeling a bound conformation.
Because of the possibility of step-wise diffusion of magnetization while the acceptor is bound
to GnT-V we used data from short mixing times (50 – 150 ms) that gave no indication of
delayed build-up in later points. In addition, only the shorter constraints of the two methylene
protons, Glc H6S and H6R, were used; this compensates for efficient spin diffusion between
these closely spaced protons. Because of missing information on the possible location of protein
protons that could act as part of the spin system, no attempts were made to model spin diffusion
more precisely.18 The distance constraints that could be determined from the trNOESY spectra
of the acceptor with GnT-V are listed in Table 1.
Structural Modeling of the Acceptor
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Simulated annealing was used to refine the structure of the bound-state acceptor using the NOE
constraints listed in Table 1. From the 100 structures generated, the 10 lowest overall energy
conformations were selected. The average torsion angles and standard deviations are listed in
Table 2 for the 10 structures (see Materials and Methods sections for torsion angle definitions).
An ensemble of structures is illustrated in Figure 7. The structures were aligned based on the
sugar ring atoms. The RMSD for the sugar ring atoms after alignment of the rings is 0.17 Å.
The RMSD for all sugar atoms is 0.56 Å and for all atoms including the octyl chain is 2.04 Å.
Placement of Donor and Acceptor by Paramagnetic Relaxation Enhancement
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The paramagnetic relaxation enhancement of the bound acceptor due to bound UDP-TEMPO
was measured by comparing the longitudinal relaxation rates (1/T1) of the acceptor protons in
a control and relaxation-enhanced sample. The relaxation-enhanced sample contained GnT-V
and a near saturating amount of UDP-TEMPO, while the control sample contained the acceptor,
GnT-V, and an appropriate amount of a soluble paramagnetic species presumed not to bind to
the protein (4-hydroxy-TEMPO). While applications of paramagnetic relaxation enhancement
on protein protons by nitroxides covalently attached to protein are now routine, several
difficulties arise when measuring perturbations of rates for protons on an exchanging ligand
in the presence of a second exchanging ligand carrying a nitroxide group. These difficulties
necessitated a rather complex experimental protocol. First, we chose to measure longitudinal
relaxation rates rather than the transverse relaxation rates that are measured in many
experiments on simple protein systems. Exchanging ligands often suffer chemical exchange
broadening of resonances that can be difficult to separate from paramagnetic transverse
relaxation effects. The longitudinal relaxation effects are small at the high fields needed to
resolve various resonances, but they are not contaminated by these additional effects. Second,
the control experiment must have the protein, GnT-V, present. Quite aside from the
perturbations by nitroxide, the protein affects relaxation of protons on the acceptor by changing
the correlation time. And third, the control experiment must have an equivalent amount of
nitroxide in solution since chance encounters of unbound acceptor and unbound donor analogue
contribute to the relaxation of protons on the acceptor. A relatively high concentration of UDPTEMPO was used to maximize the percentage of GnT-V occupied (estimated at 70% at 10
mM UDP-TEMPO). This high concentration, in turn, required careful consideration of an
appropriate control for nitroxide induced relaxation in solution. The solution effects of UDPTEMPO were experimentally found to result in a 3-fold decrease in the T1 values of the
acceptor protons. The concentration of hydroxy-TEMPO required to match the T1 reduction
was found to be 6.85 mM, somewhat lower than expected, possibly because of incomplete
oxidation of the UDP-TEMPO to nitroxide.
J Mol Biol. Author manuscript; available in PMC 2008 March 2.
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The change in relaxation rates on comparing UDP-TEMPO to 4-hydroxy-TEMPO samples are
plotted in Figure 8 for the GlcNAc, Man, and Glc residues of the acceptor. A positive change
indicates paramagnetic perturbation from bound UDP-TEMPO to the bound acceptor. Data
for the octyl chain was not included since the trNOESY and refined structures suggest that this
residue is flexible in the binding pocket of GnT-V; and, paramagnetic relaxation enhancement
of these flexible residues would be heavily biased towards close, intermittent contacts with
UDP-TEMPO. The paramagnetic perturbation from UDP-TEMPO is most apparent around
the Man and Glc protons and apparent to a lesser extent around the GlcNAc protons. The Nacetyl methyl protons and H5’ could not be measured in the 1H-13C HSQC due to overlap from
GnT-V oligosaccharide signals.
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The change in the longitudinal relaxation rate for the sugar residues is actually small, ranging
from −0.06 to 0.86 s−1. This is partly due to the fact that paramagnetic effects on longitudinal
relaxation rates by nitroxides are inherently small at high magnetic fields, and partly due to the
dependence on the fraction of the acceptor bound to GnT-V at the same time as UDP-TEMPO.
Assuming a Kd of 12.8 μM19 for the acceptor and 4.4 mM for UDP-TEMPO (UDP-GlcNAc
Kd = 4.4 mM),17 the experimental sample of 155 μM GnT-V, 2 mM acceptor, 10 mM UDPTEMPO would give only 5.3% of the acceptor bound to UDP-TEMPO-occupied GnT-V. If a
fraction of the UDP-TEMPO was in the reduced form, then this percentage would be even less.
It would clearly be advantageous to have nitroxide labeled analogues with higher affinities for
these experiments. Nevertheless, some useful data can be extracted. The propagated standard
error is 0.23 s−1 based on the standard error from the exponential fit of the peak volume data
from the incremented time delay 1H-13C HSQC spectra. The enhanced relaxation of H3, H5,
and H6S on the Glc residue and H6S and H2 on the Man residue are clearly significant, as are
the absence of significant effects on the GlcNAc residue. These data are useful in placing the
donor relative to the acceptor in the active site.

Discussion
Binding Epitopes of Donor and Acceptor
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Important parts of the binding epitope of UDP-GlcNAc are clearly indicated in saturation
transfer difference data for this ligand. More efficient magnetization transfers indicate short
ligand proton - protein proton distances for the uracil H6 and H5 and ribose H1’, H2’, and H3’
protons, and less efficient magnetization transfers indicate somewhat longer distances for
protons in the GlcNAc ring. The close contacts for the uracil ring and its attached ribose are
consistent with evidence that UDP serves as an efficient competitive inhibitor of GnT-V with
a Kd of 3.8 mM.17 The lesser contacts with the GlcNAc residue are consistent with the necessity
of leaving at least the anomeric region of this ring exposed for addition to the acceptor. The
binding epitope determined for UDP-GlcNAc bound to GnT-V supports increasing evidence
that the uridine portion acts as a recognition motif for glycosyltransferases utilizing UDP-sugar
donor substrates while recognition of the sugar portion provides specificity.20
The binding epitope of UDP-TEMPOH was determined in order to verify binding to GnT-V
and preservation of a binding epitope similar to that of UDP-GlcNAc. The reduced form of
UDP-TEMPO was used because the nitroxyl radical form is paramagnetic and the 1H signals
from UDP-TEMPO are greatly attenuated due to paramagnetic relaxation. Since the reduction
results only in the addition of a single hydrogen to the nitroxide oxygen, the results on UDPTEMPOH are assumed to yield a good representation of the UDP-TEMPO epitope. The results
for the STD experiment with UDP-TEMPOH shown in Figure 3 indicate strong contacts to
the uracil H6 and H5 and ribose H1’, H2’, and H3’ protons. The values across the molecule
are similar to those of UDP-GlcNAc with the exception of R1’ which shows a higher STD
contact in UDP-TEMPOH. The STD enhancement of R1’ may be due to differences in the offrates of UDP-TEMPOH compared to UDP-GlcNAc, and with this single exception, the overall
J Mol Biol. Author manuscript; available in PMC 2008 March 2.
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catalytic donor site of GnT-V.
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The binding epitope of the acceptor is also well defined by STD data. The closest protein proton
– ligand proton distances for the acceptor are localized on the β-(1→2)-GlcNAc ring and the
octyl chain. The strong STD contacts of the octyl chain may be a result of interaction with a
hydrophobic pocket in the acceptor catalytic site of GnT-V or even non-specific interactions
with other sites on the protein. In either case, the octyl chain is not a structurally important
element of the native acceptor. The β-(1→2)-GlcNAc ring contacts are more interesting. The
closest contacts to GnT-V protons on the β-(1→2)-GlcNAc ring are H3”, H4”, H5”, and
H6S” (see Figure 1) with relative STD percentages of 52, 67, 70, and 80%. Compared to the
STD values for the Man and Glc rings which range from 22 to 44%, the contacts to the GlcNAc
ring are significant. The presence of β-(1→2)-GlcNAc at the non-reducing terminus of the
acceptor substrate is known to be essential for activity with GnT-V.21 Additionally, trNOESY
data comparing acceptor analogues with and without a terminal GlcNAc, namely β-DGlcpNAc-(1→2)-α-D-Manp-(1→3)-[β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)]-D-Manp and
α-D-Manp-(1→3)-[α-D-Manp-(1→6)]-α-D-ManpOMe, indicate that the β-(1→2)-GlcNAc is
important for binding to GnT-V at least in the fast exchange regime (data not shown).
Furthermore, structure activity relationships determined by Kanie, et al. show that OH-3”,
OH-4”, and OH-6” of this acceptor are key recognition elements by GnT-V.22,23 Modification
of these hydroxyl groups to NH2 and NHAc groups resulted in 23 to 230-fold higher Km values
for the 3”-modified and 4”-modified acceptor analogues and no activity up to 10 mM for the
6”-modified acceptor analogues. The STD data indicating very close GnT-V proton distances
to H6S” (80% STD) would be consistent with an inability to modify this site; lesser distances
for H3” and H4” (52% and 67% STD, respectively) suggest proximities where small
modifications might improve protein interaction. Taken together, the data indicate a sterically
restricted interaction between the catalytic site of GnT-V and the 3”, 4”, 5”, and 6” end of the
GlcNAc ring.
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Weaker STD contacts are seen for the Man and Glc rings. The weak Man contacts, particularly
around the H5’ and H6’ sites are again consistent with the need to keep this region open to
addition of a GlcNAc from the acceptor. However, these weaker STD signals, particularly for
the acceptor, require careful interpretation. STD contacts can be strongly influenced by spin
diffusion during the time spent in the protein binding site. We do not have independent
information on the lifetime of the acceptor in the binding site, but the low dissociation constant
(Kd = 12.8 μM) would support a longer residence time for the acceptor than the donor. Spin
diffusion can distribute saturation occurring at a strongly interacting site to adjacent sites in
the ligand, tending to reduce STD variations across the molecule. We also have to be careful
in interpreting that lack of STD intensity as a lack of protein contact. Longer contacts such as
those mediated by hydrogen bonding interactions are not easily observed. In our case,
deuteriums from the solvent replace the protons actually in the hydrogen bonds. Hence, any
inter-proton distance interpretations need to stay at a qualitative level.
Nevertheless, the qualitative results we do have can be supported with data from other sources.
For example, there are structure-activity relationships to support modest interactions at the
Man and Glc rings. While, removal of the Glc ring from the acceptor has been shown to produce
a very poor substrate for GnT-V, modifications to the Glc ring are well-tolerated by GnT-V.
For example, O-benzylating the hydroxyl groups of Glc is allowed (Km increases by a factor
of 2), indicating little steric restriction around the Glc residue by GnT-V.24 Likewise,
modification of the OH-3’ to O-methyl in the Man residue has only a small effect on the activity
of GnT-V.25 O-methylation of OH-4’ results in no activity, but does not affect its binding.
26 Given the lower saturation transfers to the Glc and Man rings and the possibility that residual
intensities are partly from spin diffusion effects, the STD results support these activity
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relationships. The absence of close contacts with GnT-V around OH-3’ or OH-4’would allow
their modification and create an ‘open’ space that is the catalytic pocket for the donor substrate,
UDP-GlcNAc.
The STD results on the acceptor in the presence of UDP are of some additional interest. The
mechanism for glycosylation by GnT-V was suggested by Zhang, et al. to be an ordered
reaction where UDP-GlcNAc binds first, resulting in a conformational change of the protein
followed by sequential binding of the acceptor substrate.17 Both UDP and UDP-GlcNAc were
suggested to induce a similar conformation change. Therefore, we might expect somewhat
different STD patterns for the acceptor in the absence and presence of UDP. However, no
significant differences in STD data in the presence and absence of UDP were found (see Figure
4). This could simply mean that UDP does not induce the same change that UDP-GlcNAc does,
or that the STD of the acceptor is not sensitive to the structural change. The result does not, of
course, rule out conformational changes in parts of the binding site that are not in close contact
with the acceptor.
Conformation of Donor and Acceptor
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Intramolecular 1H-1H distance constraints determined using trNOE and trNOESY experiments
on UDP-GlcNAc bound to GnT-V provide a reasonable picture of the bound conformations
of the donor. Only one restraining trNOE was observed for both UDP-GlcNAc, and that was
between H6 and H2’. It corresponds to a distance of 2.5 Å. This is consistent with the anti
glycosidic torsion angle known to be adopted by most pyrimidine nucleosides in solution;27
thus there is little conformational change of the uridine portion of UDP-GlcNAc compared to
free UDP-GlcNAc. The fact that no NOE contacts are observed between the uridine portion
of the molecule and the GlcNAc prevents a complete conformational determination, but it does
eliminate a folded conformation that would have short distances between protons on the
respective moieties as was recently observed for UDP-Gal bound to a galactosyltransferase in
the presence of Mg2+.28 These results suggest that GnT-V binds in a low energy conformation
such as those found in solution or sugar nucleotide containing crystal structures.
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For the acceptor, the conformational data from transferred NOE experiments is quite rich. Most
of the constraints (see Table 1) involve the Man and GlcNAc rings, and in particular the Nacetyl group. These restrain the bound conformation of the Man and GlcNAc rings to a well
defined conformation. Constraints to the Glc ring exist, but most of the constraints involve the
exocyclic methylene protons which are subject to efficient spin-diffusion due to the short
distance between the methylene protons. Only constraints to the methylene showing the
strongest NOE were used (H6S) assuming the NOE to H6R was heavily contaminated by spin
diffusion. Nevertheless, even with a reduced set of constraints, the Glc ring is restrained with
respect to the Man and GlcNAc rings. There are no contacts between the octyl chain and the
Man or the GlcNAc rings, suggesting isolation of these two sugar rings from the octyl chain
in the bound conformation. To get a picture of the conformation of the acceptor in the active
site of GnT-V, distance constraints derived from the NOEs were used to refine a structure using
simulated annealing.
The results from the simulated annealing of the acceptor using the trNOE distance constraints
resulted in a distinct conformation with little variation between the 10 lowest energy structures.
The standard deviations of the torsion angles for the β-D-GlcpNAc-(1→2)-α-D-Manp linkage,
the α-D-Manp-(1→6)-β-D-Glcp linkage, and the N-acetyl group are very low ranging from 2
– 11 degrees. Less well-defined are the exocyclic OH-6 groups of GlcNAc and Man and the
Glc-octyl chain linkage. The OH-6’ of Man is important because it is the site of catalytic
addition of a GlcNAc residue by GnT-V. The torsion angle, χ5, confines the position of OH-6’
to -39 degrees with a standard deviation of 59 degrees. This deviation is small enough to restrict
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the rotation to the tg rotamer conformation (-60 degrees) (see Materials and Methods sections
for a description of the naming conventions).
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To assess whether the above structure is reasonable, comparisons to other carbohydrate
structures and structure activity relationships were made. The GlyTorsion database was used
to compare known carbohydrate structures with the refined bound-state acceptor structure.29
The database reports on torsion angles from structures in the Protein Data Bank (PDB).8 No
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data was available for α-D-Manp-(1→6)-β-D-Glcp linkages since this is not a typical linkage.
However, data on α-D-Manp-(1→6)-β-D-Manp is available for comparison. The difference
between Man and Glc is a change in the stereocenter of the C2 ring atom; thus, a change from
Glc to Man is not expected to significantly affect the torsion angles of the (1→6) linkage. Plots
of the φ, ψ, andω torsion angles for the α-D-Manp-(1→6)-β-D-Glcp linkage of the refined
acceptor are shown in Figures 9a and 9b along with the GlyTorsion data for α-D-Manp-(1→6)β-D-Manp linkage. Even though the φ and ψ torsion angles for the refined acceptor structure
do not fall within the most concentrated areas of GlyTorsion data, they do fall within the range
of torsion angles for known structures. The ω torsion angles lie in one of the two highly
concentrated areas at 60 degrees, the gg conformation. This conformation is also supported by
solvated molecular dynamics simulations30 and 1H NMR spectroscopy31 of methyl α-Dglucopyranoside, which predict that the gg conformation is the most highly populated. A plot
of the φ and ψ torsion angles for the β-D-GlcpNAc-(1→2)-α-D-Manp linkage and the χ2a and
χ2b exocyclic angles for the N-acetyl group of β-D-GlcpNAc are included in the supplementary
materials. The values for the refined structures fall within the range of values found in the PDB
for both the β-D-GlcpNAc-(1→2)-α-D-Manp linkage and the χ2a and χ2b exocyclic angles,
indicating that the GlcNAc and Man rings are in a reasonable geometry with respect to each
other. These results indicate that the refined conformation of the bound-state acceptor is a
reasonable structure.
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In addition to agreeing with known structural data, the conformation of the bound-state acceptor
structure agrees with known structure activity relationships. The conformation of the α-DManp-(1→6)-β-D-Glcp linkage is supported by data from Bock, et al., who showed a strong
preference for the gg conformation of the acceptor analogue by GnT-V over the gt conformation
using restricted ω torsion angle acceptor analogues.16 The acceptor structure is also consistent
with the acceptor analogue modifications described earlier in the binding epitope discussion.
Even the large modifications such as O-benzylating the hydroxyl groups of Glc would be
spatially allowed based on the proposed acceptor structure.24 One feature of the refined boundstate acceptor structure is seemingly inconsistent with structure activity relationship data. This
feature involves the position of OH-6’ of the Man residue, which, based on our data, is predicted
to be in the tg rotamer conformation. This conformation has been shown to be a weakly
populated conformation based on solvated molecular dynamics calculations using the model
compound, methyl α-D-glucopyranoside.30 However, in the absence of modeled water, the
tg rotamer conformation is of low energy due to intramolecular hydrogen bonding between
OH-6 and O-4. Thus, our predicted acceptor structure indicates that OH-6’ and O-4’ of the
Man residue may be forming a hydrogen bond in the bound-state. Structure activity relationship
of OH-4’ derivatives from Khan, et al. showed increased GnT-V activity with a 4’-deoxy
acceptor analogue, and no activity, but retention of binding capacity with the 4’-methyl
acceptor analogue.25 These results were interpreted as no catalytically important role for
OH-4’, since the 4’-deoxy derivative was active. In our structure it may be that the tg
conformation persists in the bound-state acceptor structure because the binding pocket of GnTV is incomplete without the sugar donor.
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Paramagnetic relaxation enhancement
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The difference in the longitudinal relaxation rate between experimental and control samples
were plotted in Figure 8 for the Man, GlcNAc, and Glc residues. As discussed in the results
section, the errors in these experiments are relatively high, but the enhanced relaxation of H3,
H5, and H6S on the Glc residue and H6S’ and H2’ on the Man residue in particular are
significant. This enhancement is consistent with approach of the TEMPO moiety from a
direction away from the GlcNAc and on the face of the Man ring between H6S’ and Glc H5.
The result is also consistent with STD data that suggests that the GlcNAc residue is in close
contact with the GnT-V surface, and thus, removed from easy contact with UDP-TEMPO. In
addition, this approach does not interfere with space around OH-4’, which we propose to be
in close proximity with the nucleophilic residue of GnT-V responsible for the activation of
O-6’.
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In Figure 10, we have assembled a model that is consistent with data on bound conformations,
STD contacts, and relative placement of ligands. This can be compared with the crystal
structure of β1,6-N-acetylglucosaminyltransferase (C2GnT-L) with its acceptor, β-D-Galp(1→3)-D-GalpNAc.32 Like GnT-V, it is an inverting glycosyltransferase, metal ion
independent, uses UDP-GlcNAc as a donor, and creates a β-D-GlcpNAc-(1→6) glycosidic
bond. In the case of C2GnT-L, the glycosidic bond is made to the GalNAc residue of the core
1 O-glycan, β-D-Galp-(1→3)-α-D-GalpNAc-O-Ser/Thr. As predicted for glycosyltransferases
of the inverting type, a nucleophilic residue, glutamate 320, forms hydrogen bonds with
GalNAc OH-4 and OH-6 in the C2GnT-L/acceptor structure. Similarly, a glutamate residue
was added to our model in Figure 10 to coordinate with Man OH-4’ and OH-6’. This scenario
is consistent with weak STD contacts to the Man ring since deuterated hydrogen bonds would
result in long protein proton – acceptor proton distances. It is also consistent with structure
activity relationship data, which shows an ability to sterically disable the catalytic reaction at
OH-4’ with methylation. The structure of UDP-GlcNAc used in the model was taken from the
crystal structure of MurG with UDP-GlcNAc.33 MurG is a metal-independent Nacteylglucosaminyltransferase, as is GnT-V, and the only enzyme of its type with a structure
including bound UDP-GlcNAc. The MurG UDP-GlcNAc structure is consistent with the
structural data determined for GnT-V UDP-GlcNAc including the trNOE distance constraint
between H6 and H2’ and the lack of distance constraints between the GlcNAc ring and uridine
portion. UDP-GlcNAc was modeled below and in front of the Man plane based on results from
the paramagnetic relaxation data from the spin-labeled donor analogue, UDP-TEMPO. While
this model is consistent with the data presented, the relative placement of UDP-GlcNAc is
speculative due to the large error in the paramagnetic relaxation enhancement experiment. In
addition, it should be noted that while the placement of the GlcNAc ring in the model is
dependent on the experimental data presented, the relative position of the uridine diphosphate
in the model is unknown and may differ from the MurG UDP-GlcNAc structure due to the
high degree of flexibility about the phosphate residues. The native acceptor structure was used
in the model to illustrate the additional volume of the native acceptor compared to the acceptor
analogue. The three sugars corresponding to the acceptor analogue were modeled with the
torsion angles determined from the NOE refinement and are indicated in Figure 10 with thick
bonds. The model is consistent with the STD data for the acceptor. Space around the GlcNAc
residue allows for protein contacts to be modeled as indicated by the dashed lines. In addition,
the lack of STD contacts to the Glc residue (Man(Glc) residue in Figure 10) can be justified
because space around this residue would be necessary to accommodate the native acceptor
with its two additional glycosidic chains. The model is a culmination of data presented here
and data acquired by others relating to GnT-V activity and glycosyltransferase structure and
mechanisms. It is intended to be used to form hypotheses to test for more structural information
on GnT-V and to design effective inhibitors for the treatment of carcinoma progression.
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In conclusion, we have provided structural characterization of the bound substrates of GnT-V
and their structural interaction with the active site of GnT-V. Data from trNOEs were
successfully used to determine the structures of the bound-state of UDP-GlcNAc and the
acceptor analogue, β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)-β-D-GlcpOOctyl. The donor
analogues show the typical anti glycosidic torsion angle for the uridine residues and indications
of a linear configuration for the molecules with no interaction between the GlcNAc and the
uridine. The trNOEs for the acceptor were successfully used with simulated annealing to refine
a structure where the GlcNAc, Man, and Glc rings are well-defined in the active site of GnTV. Binding epitopes for the donor analogues were consistent with binding of
glycosyltransferases to nucleotide sugars with close contacts from the binding pocket of the
GnT-V to the uridine residues. The binding epitope of the acceptor indicated close contacts
between the GlcNAc ring and GnT-V, consistent with known substrate activity of GnT-V and
structure-activity relationships of the acceptor analogue with GnT-V. A novel paramagnetic
relaxation enhancement experiment was performed to determine the distance and relative
orientation of the donor and acceptor substrate pair in the active site of GnT-V. Even though
spin diffusion effects prevent a quantitative analysis of the latter data, a qualitative
interpretation, combined with the conformations and protein surface contacts determined for
the two ligands, leads to a model that is consistent with mechanistic expectations. The model
also provides a basis for the design of inhibitors that may span parts of both ligands, and may
make contacts with more extended regions of the protein binding site.
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Materials and Methods
Preparation of protein samples
Recombinant soluble human GnT-V was expressed in Chinese hamster ovary (CHO) cells and
purified from concentrated media as described previously.9,10 The activity of GnT-V was
determined by radiochemical assay as described previously.12 Gel electrophoresis indicated
that 80% of the purified GnT-V was the full length 95 kDa construct while the remaining 20%
was a known, active proteolytic fragment of 66 kDa.12 To prepare samples for NMR
spectroscopy, purified GnT-V was dialyzed and concentrated in NMR sample buffer (50 mM
potassium phosphate (pH 6.5), 100 mM NaCl, D2O). Coomassie Plus reagent and an albumin
standard were purchased from Pierce Biotechnology, Inc. and used to determine the
concentration of GnT-V using a spectrophotometric (595 nm) protein assay. Concentrations
of GnT-V in the range of 50 – 250 μM were used for the experiments.
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Small molecule components including donor and acceptor analogues were prepared as stock
solutions at 30 – 50 mM concentrations for addition to GnT-V samples. Uridine 5’-diphosphate
sodium salt (UDP), uridine 5′-diphospho-N-acetylglucosamine sodium salt (UDP-GlcNAc),
and 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (4-hydroxy-TEMPO) were purchased
from Sigma-Aldrich. β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)-[β-D-GlcpNAc-(1→2)-α-DManp-(1→6)]-D-Manp and α-D-Manp-(1→3)-[α-D-Manp-(1→6)]-α-D-ManpOMe were
purchased from Dextra Laboratories Ltd. The acceptor substrate of GnT-V, β-D-GlcpNAc(1→2)-α-D-Manp-(1→6)-β-D-GlcpOOctyl,11 was purchased from Rose Scientific Ltd. 6Acetamido-6-deoxycastanospermine was purchased from Industrial Research Ltd and used as
a β-N-acetylglucosaminidase inhibitor to protect the acceptor substrate from degradation due
to a contaminating hexosaminidase.34 Inhibitor concentrations of 10 mole percent relative to
GnT-V were used in all samples containing GnT-V and acceptor substrate. The activity of
GnT-V was not affected by the inhibitor.
IUPAC conventions were used throughout the text to define the dihedral angles of the acceptor
substrate, β-D-GlcpNAc-(1→2)-α-D-Manp-(1→6)-β-D-GlcpOOctyl: φ = O5(i)-C1(i)-On(i −
1)-Cn(i −1), ψ = C1(i)-On(i −1)-Cn(i −1)-C(n −1)(i −1), ω = O6(i)-C6(i)-C5(i)-C4(i), where
(i) indicates a given residue and (n) a ring position.35 Exocyclic torsion angles are named χn,
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where (n) is the ring position of the side group; for example, χ5 refers to the torsion angle for
the exocyclic 6-hydroxymethyl groups on GlcNAc and Man (C4-C5-C6-O6). The exocyclic
torsion angles for the N-acetyl group on GlcNAc are χ2a (C1-C2-NNAc-CNAc) and χ2b (C2NNAc-CNAc-ONAc). The gg, gt, tg naming convention was used to describe the α-D-Manp(1→6)-β-D-Glcp ω rotamer conformation and the χ5 rotamer conformations. Each character
refers to a torsion angle being either gauche (g) or trans (t), where the first character describes
the O6(i)-C6(i)-C5(i)-O5(i) dihedral angle and the second describes the O6(i)-C6(i)-C5(i)-C4
(i) dihedral angle.
Synthesis of UDP-TEMPO
Uridine 5′-diphospho-4-O-2,2,6,6-tetramethylpiperidine 1-oxyl (UDP-TEMPO) was
synthesized following the procedure reported by Berliner and Wong with some experimental
modifications.36 In particular, it was observed that the 300 MHz NMR of two commercial
samples of 4-phosphonooxy-TEMPO in D6 DMSO show that the product had degraded.
Therefore this intermediate was synthesized following published procedures.37
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Uridine 5’-monophosphomorpholidate-4-morpholine-N,N’-dicyclohexylcarboxamidine salt
was purchased from Sigma. Other chemicals used in the synthesis were purchased from
Aldrich. Pyridine was dried by distillation over calcium hydride and kept on activated
molecular sieves. Reactions were run under argon. Solvents, water and pyridine were
evaporated under reduced pressure with a bath temperature under 32°C. Iatrobeads 6RS-8060
used in the purification were purchased from Bioscan. Thin layer chromatograms were run on
Merck Kieselgel 60 F254 aluminium coated plates.
2,2,6,6-Tetramethyl-4-phosphopiperidine-1-oxyl pyridinium salt (4phosphonooxy-TEMPO)—Barium cyanoethylphosphate hydrate (4 g, 12.4 mmol) was run
through a column of Dowex 50 x 4 (H+ form, about 65 g) and eluted with water. The appropriate
fractions were freeze dried and the residue co-evaporated three times with dry pyridine
providing the pyridinium salt (2.89 g). 4-hydroxy TEMPO (0.516 g, 3.0 mmol) was added to
a solution of the above material in dry pyridine (15 mL). The pyridine was evaporated and the
operation repeated two times. Dicyclohexyl carbodiimide (3.0 g, 15 mmol) was added to a
solution of the above recovered mixture in dry pyridine (15 mL). After 2 days at room
temperature, TLC (80:20 CHCl3, CH3OH) indicated the disappearance of the starting 4hydroxy TEMPO. Water (5 mL) was added and the mixture was vigorously stirred and then
filtered. The flask and the precipitate were further washed with water (20 x 2 mL). Lithium
hydroxide (0.6 g) was then added and the mixture refluxed for 1 h. The insoluble material was
removed by filtration, half of the water was evaporated, the mixture further filtered, and the
solution finally concentrated by evaporation.
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The above material was run through a column of Dowex 50 x 4 (pyridinium form, 30 g) with
water as eluant and the recovered orange fractions evaporated to provide a residue which was
dried in vacuo. The recovered material dissolved in the strict minimum amount of methanol
was loaded onto a column of Iatrobeads (15.5 g) and the product eluted with a 70:30:4 mixture
of chloroform, methanol and water to provide the expected material as an orange sticky solid
(0.260 g, 21 %). 1H-NMR resonance assignments are included in the supplementary materials.
Integrals from the 1H-NMR spectrum indicated that the material was likely to be a dipyridinium salt.
Uridine 5’-diphosphate-4(2,2,6,6-tetramethylpiperidine-1-oxyl) ammonium salt
(UDP-TEMPO)—The above nitroxide intermediate (0.260 g, 0.685 mmol) was evaporated 3
times with 5 mL of dry pyridine. UMP-morpholidate (0.646 g, 0.942 mmol) and tetrazole (3.2
mL of a 3% solution in acetonitrile, 1.1 mmol) were also evaporated 3 times with dry pyridine
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and added to the UMP-morpholidate with 5 mL of dry pyridine. The mixture was stirred at 25°
C for 5 days. TLC (chloroform, methanol water 80:20:1) indicated the disappearance of the
TEMPO-phosphate. The pyridine was evaporated in vacuo and the crude material divided in
two portions separately purified by ion exchange chromatography on DOWEX 1 x 8 (200
mesh, HCO2−, 12 x 1 cm) and eluted with a gradient of NH4+ HCO2− (0.1–0.6 M). The
recovered fractions were checked by TLC (3:2:1 isopropanol, ammonium hydroxide, water)
and the results indicated a mixture of the expected product and hydrolyzed UDP. Fractions
containing the upper spot were pooled, co-evapotated with an excess of distilled water and
finally freeze dried providing 0.324 g dry yellowish solid. UDP-TEMPO was finally obtained
after chromatography of the previous solid material (0.241 g) directly on a small column of
Iatrobeads (3.5 g) packed in 90:10 isopropanol and ammonium hydroxide. Elution with a
80:20:1 mixture of isopropanol, ammonium hydroxide and water separated some impurities
(TLC 3:2:1 of the same mixture) from the UDP-TEMPO (0.118 g, ammonium salt, yellowish
solid). The recovered material was divided in two portions and further chromatographed on
Biogel P2 (75 x 1.5 cm) using water as eluant. Appropriate yellowish fractions were collected
and freeze dried providing the UDP-TEMPO (96 mg, ammonium salt, yellowish dry
foam). 1H-NMR resonance assignments are included in the supplementary materials.
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A reduced form of UDP-TEMPO (UDP-TEMPOH), where the oxyl radical is reduced to a
hydroxyl group, was prepared by the addition of phenylhydrazine to 2.4 mg of UDP-TEMPO
in deuterated methanol. Reduction was monitored with 1H NMR by the appearance of signals
from UDP-TEMPOH. Water was added to the sample and the phenylhydrazine was extracted
under argon with ethyl ether and dicholormethane. After the sample was dried, 2.0 mg of UDPTEMPOH was recovered and analyzed with 1H NMR to verify complete removal of
phenylhydrazine and reduction.
NMR Spectroscopy
Literature-based NMR resonance assignments of UDP-GlcNAc and β-D-GlcpNAc-(1→2)-αD-Manp-(1→6)-β-D-GlcpOOctyl were confirmed using 1H-1H correlation spectroscopy
(COSY), 1H-1H total correlation spectroscopy (TOCSY), and 1H-13C HSQC experiments.
15,16
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The binding epitope of the acceptor, UDP-GlcNAc, and UDP-TEMPOH were determined
using the NMR saturation transfer difference (STD) experiment. Individual samples were
prepared in 50 mM potassium phosphate, pH 6.5 (not corrected for deuterium), 100 mM NaCl,
D2O buffer. To produce spectra for protein background subtraction, additional samples of GnTV were prepared and run at identical experimental conditions as the ligand experiments.
Reference spectra of each ligand in buffer were also collected using the standard single pulseacquire 1H experiment. STD experiments generally follow those described by Mayer and
Meyer except protein background was subtracted rather than using a T1ρ filter.38 Other
experimental conditions and parameters for the STD experiments for the acceptor, UDPGlcNAc, and UDP-TEMPOH are listed in Table 3. A Gaussian π pulse was used in the pulse
train to saturate the protein in each experiment.
Transferred nuclear Overhauser effect (trNOE) experiments were used to determine
intramolecular distances for the acceptor, UDP-GlcNAc, and UDP-TEMPOH in the presence
of GnT-V. Samples were prepared with free substrates and the substrates with GnT-V. Sample
and NMR experimental conditions for the trNOE and trNOESY experiments are listed in Table
4. Both experiments included a z-filter for zero quantum coherence suppression which reduces
line-shape distortions at short mixing times.39 The analysis of the 1D trNOE spectra of UDPGlcNAc and 2D trNOESY spectra of UDP-TEMPOH involved volume integration of H6, H5,
and R2’. The percent NOE was calculated for the H6-H5 and H6-H2’ pairs and plotted against
the mixing time. The initial slopes of the NOE buildup curves and the H6-H5 reference distance
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of 2.43 Å were used to calculate the H6-H2’ distance. The analysis of the trNOESY spectra of
the acceptor with GnT-V involved assignment of the crosspeaks and volume integration using
NMRPipe40 and NMRView,41 respectively. 1H-1H distances within each sugar ring were
taken from an energy minimized structure of the acceptor to use as reference distances. The
inter-ring and exocyclic group distance constraints were calculated using the reference
distances and the slopes from NOE buildup curves (peak volume versus mixing time).
Simulated Annealing
Xplor-NIH was used to refine the structure of the bound-state acceptor substrate using the NOE
constraints listed in Table 1 and simulated annealing.42 Parameter and topology files were
generated using standard files from Xplor-NIH for the carbohydrate portion of the acceptor
and PRODRG for the octyl chain.43 A standard simulated annealing protocol from the XplorNIH on-line manual was used to refine the structure. A starting temperature of 1000 K was
used with 2 fs time steps for the 12 ps high-temperature stage and 6 ps cooling stage. 100
structures were generated and the 10 lowest energy structures were selected. No NOE violations
(outside of ± 0.5 Å) occurred for the 10 lowest energy structures.
Paramagnetic Relaxation Enhancement
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Paramagnetic relaxation enhancement of the bound acceptor protons induced by bound UDPTEMPO was measured by comparing the proton T1 relaxation times of an experimental and
control sample. The experimental sample was 155 μM GnT-V, 2 mM acceptor, and 10 mM
UDP-TEMPO. The control sample was 155 μM GnT-V, 2 mM acceptor, and 6.9 mM 4hydroxy-TEMPO. The effective T1 relaxation times of the experimental and control samples
were determined using a 1H-13C heteronuclear single quantum correlation (HSQC) experiment
with recycle delay times of 0.25, 0.5, 1, and 2 seconds (including acquisition time). An effective
T1 value for each sample and each cross-peak was determined by fitting the peak volume versus
overall delay time (t) with the exponential equation: c*[1−exp(−t/T1)]. The HSQC experiment
used was a modified version of Varian’s ProteinPack HSQC with gradients for 13C/1H chemical
shift correlation. The experiment was optimized for natural abundance carbohydrates by
replacing the selective carbon pulses with hard pulses and using the sensitivity enhancement
option. WURST decoupling was used with a bandwidth of 32 kHz during the 50 ms acquisition
time. A 13C sweep width of 6 kHz was used resulting in folding of the anomeric and octyl
chain peaks with 64 time increments. The 1H spectral window (6.8 kHz) was centered at the
water peak and the width adjusted to contain all acceptor peaks. The HSQC spectra were
processed with NMRPipe40 with a 20 Hz Gaussian weighting function along the direct
dimension to smooth the highly J-coupled peaks to one line. Linear prediction and a cosine
squared weighting function were used along the indirect dimension to improve the signal-tonoise ratio. The peak volumes were measured using NMRView.41
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Figure 1.

(a) The reference 1D 1H NMR spectrum of the acceptor in deuterated buffer solution including
assignments. An exponential weighting function of 5 Hz was applied to mimic the linewidth
of the acceptor in the STD spectrum. Chemical shift overlap of the octyl chain methylenes,
H3/H4, H5’/H6R’, and H6S/H6R” pairs could not be resolved at 900 MHz. (b) The STD
spectrum of the acceptor with GnT-V using a 100 Hz Gaussian saturation pulse train of 500
ms centered at 0.0 ppm. (c) The normalized percentages calculated from the STD and reference
spectra of the acceptor are superimposed on the chemical structure of the acceptor.
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Figure 2.

(a) The reference 1D 1H NMR spectrum of UDP-GlcNAc in deuterated buffer solution. The
asterisk indicates acetone, which was used as a chemical shift reference. An exponential
weighting function of 4 Hz was applied to mimic the linewidth of UDP-GlcNAc in the STD
spectrum. (b) STD spectra of UDP-GlcNAc with GnT-V using a 100 Hz Gaussian saturation
pulse train of 2.0 s centered at 0.0 ppm. (c) The normalized percentages calculated from the
STD and reference spectra of UDP-GlcNAc are superimposed on the chemical structure of
UDP-GlcNAc.
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Figure 3.

(a) The reference 1D 1H NMR spectrum of UDP-TEMPOH in deuterated buffer solution. The
asterisk in the spectrum indicates acetone, which was used as a chemical shift reference. An
exponential weighting function of 2 Hz was applied to mimic the linewidth of UDP-TEMPOH
in the STD spectrum. (b) The STD spectrum of UDP- TEMPOH with GnT-V. (c) The
normalized percentages calculated from the STD and reference spectra of UDP- TEMPOH are
superimposed on the chemical structure of UDP- TEMPO. Peaks from H2’ and H3’ are
overlapped giving an average STD value.
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STD data for the acceptor plus GnT-V without (black) and with UDP (gray). Each set was
normalized to 100% using the peak height of the acceptor octyl chain methylene signal
(CH2-6). The STD patterns are similar for both conditions suggesting little conformational
change around the acceptor binding pocket due to UDP binding.
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Figure 5.

NOE buildup curves for contacts to uracil-H6 in the absence (free, circles) and presence (bound,
squares) of GnT-V. The initial slopes of the curves were used to calculate the distance between
uracil-H6 and ribose-H2’ in the free and bound states using the distance between uracil-H6
and -H5 as a reference. Smooth curves were added to data points for better visualization.
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Figure 6.

Expanded (carbohydrate region) NOESY spectra of (a) the acceptor, (b) the acceptor in the
presence of GnT-V, and (c) GnT-V background. These allow assessment of conformational
changes on binding to GnT-V.
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Figure 7.

The 10 lowest energy structures from NOE restrained simulated annealing were aligned using
the sugar ring atoms.
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Figure 8.

The difference in the longitudinal relaxation rates (1/T1) of the acceptor in the control and
experimental samples. A positive change indicates an increase in the longitudinal relaxation
rate of the acceptor from paramagnetic relaxation enhancement by bound UDP-TEMPO.
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Figure 9.

Plot of the φ, ψ, andω torsion angles for the α-D-Manp-(1→6)-β-D-Manp linkages from the
GlyTorsion database (gray circles) and the α-D-Manp-(1→6)-β-D-Glcp linkage of the NOE
refined structures of the acceptor (black x).
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The native N-linked oligosaccharide acceptor, β-D-GlcpNAc-(1→2)-α-D-Manp-(1→3)-[β-DGlcpNAc-(1→2)-α-D-Manp-(1→6)]-α-D-Manp-(1→4)-β-D-GlcpNAc-(1→4)-β-DGlcpNAc, is used to illustrate the structural information gained from this study. The three
sugars highlighted with thick bonds represent the portion of the native acceptor retained in the
analogue used in this study. The placement of the other sugars in the native acceptor structure
illustrates the additional volume needed for the native acceptor compared to the analogue.
Saturation transfer difference results are illustrated with dashed lines to indicate proximate
residues from GnT-V. A single point is drawn to indicate the approximate location of the
nitroxide radical of UDP-TEMPO based on the paramagnetic relaxation data. The structure of
UDP-GlcNAc was taken from the crystal structure of MurG-UDP-GlcNAc33 and was placed
such that the anomeric carbon is positioned for attack by Man O-6’ and the OH-4 of UDPGlcNAc is near the UDP-TEMPO nitroxide point. A glutamate residue was added on the
opposite plane of the Man ring from the UDP-GlcNAc approach positioned to extract the proton
from Man OH-6’.
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Table 1
1H-1H

distances determined from trNOEs for the acceptor in the presence of GnT-V.a
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O-Octyl
Glc
Man'
GlcNAc”
Distance(Å)
CH2-1b
H1
----3.0
CH2-1a
H1
----3.0
CH2-2
H1
----3.5
--H5 - H6(S)
----2.2
--H1 - H6(S)
----3.3
--H6(S)
H1'
--2.5
--H6(S)
H2'
--2.9
--H4
H3'
--3.0
--H5
H1'
--3.5
--H4
H1'
--3.9
--H6(S)
--H1”
3.0
--H6(S)
--NAc
3.6
----H4' - H6'(S)
--2.9
----H2'
H1”
2.6
----H1'
H1”
2.7
----H2'
H5”
3.5
----H1'
NAc
3.5
----H3'
H1”
3.6
----H6'(S)
NAc
3.6
----H2'
H4”
3.7
----H1'
H5”
4.1
----H2'
NAc
4.8
----H4'
NAc
4.9
------H5” - H6”(R)
2.5
------H5” - H6”(S)
2.5
------H4” - H6”(S)
3.1
------H2” - NAc
4.0
------H1” - NAc
4.5
------H3” - NAc
4.8
a
Only intermolecular and sugar methylene proton NOEs were included to simplify the table. Intramolecular NOEs were used as reference values to
calculate the tabulated NOE values.
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Table 2

The average torsion angles and standard deviation of the 10 acceptor structures produced by simulated annealing
with NOE refinement.
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Residue or Linkage
GlcNAc
GlcNAc
GlcNAc
GlcNAc(1–2)Man
GlcNAc(1–2)Man
Man
Man(1–6)Glc
Man(1–6)Glc
Man(1–6)Glc
Glc(1-O)Octyl
Glc(1-O)Octyl

Torsion angle
χ5
χ2a
χ2b
φ
ψ
χ5
φ
ψ
ω
φ
ψ

Average (degrees)
−160
78
10
−107
−84
−39
116
119
60
−111
−126

Standard deviation (degrees)
83
11
5
7
2
59
3
6
3
43
56
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Table 3

NMR and sample conditions for STD experiments.
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Substrate
Acceptor
Acceptor with 10 mM UDP
UDP-GlcNAc
Concentration (mM)
2.0
2.0
2.5
GnT-V concentration (μM)
100
100
100
Magnet strength (MHz)
900
900
600
Saturation bandwidth (Hz)
100
100
100
Saturation frequency (ppm)
0.0
0.0
0.0
0.5
0.5
2.0
Saturation time (s)a
a
The total saturation time includes the delay (1 ms) between the Gaussian pulses in the cycled pulse train.
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UDP-TEMPOH
1.5
60
600
50
7.1
1.9
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Table 4

NMR and sample conditions for trNOE and trNOESY experiments.
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Sample

UDPGlcNAc

UDPGlcNAc

2D NOESY

UDPGlcNAc/
GnT-V
1.15
46
2D NOESY

1D NOEa

UDPGlcNAc/
GnT-V
1.5
60
1D NOEa

Substrate concentration (mM)
GnT-V concentration (μM)
Experiment

5

Magnet strength (MHz)
Temperature (ºC)
Mixing times (ms)

500
25
100, 300,
500, 1000

500
25
100, 300,
500, 1000

600
10
25, 50,
75, 100,
150, 200

600
10
25, 50,
75, 100,
150, 200

5

a

Acceptor

Acceptor/
GnTV

2

2
100
2D ZQ
filtered
NOESY
900
25
50, 75,
100, 125,
150

2D ZQ
filtered
NOESY
900
25
100, 200,
300, 400,
500

1D trNOE experiment was performed with selective saturation of uracil H6 with a 50 Hz bandwidth selective pulse.
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GnT-V

100
2D ZQ
filtered
NOESY
900
25
200

UDPTEMPOH/
GnT-V
1.5
60
2D ZQ
filtered
NOESY
600
25
50, 100,
300, 500

